Our results indicate that CsV may be a potential drug to treat PD by down-regulating intracellular ROS, mitochondrial membrane potential, and apoptosis, which are possibly mediated through Sirt1/MnSOD and GRP78/Caspase-12 pathways. Here, HSPA5 is linked to Parkinson disease.